Abstract
Objective
The aim of the investigation was to study the effects of withdrawing selective serotonin reuptake inhibitor (SSRI) drugs in nursing home patients, who had no documented diagnosis or symptoms of depression.
Setting
The setting of the study was in 11 nursing homes in the county of Stockholm, Sweden.
Participants
Participants were patients without dementia or history of depression who had received treatment with SSRI drugs for more than 6 months and who had no indications of anxiety disorder or major depression
Design
The included patients (n=70) were randomized to either the intervention group (withdrawal of SSRI) or the control group (no change in treatment), 35 patients to each group.
Main outcome measures
The patients were subjected to assessment using the following instruments: Montgomery-Åsberg depression rating scale, global assessment for functioning, health index and a symptom assessment form. Assessment was made at the start of the study and at the 3-month and 6-month follow-ups.
Results
We found no significant difference between the intervention and control groups in any outcome measure.
Conclusion
Treatment with SSRI drugs in patients without clinical major depression or anxiety disorder is often unjustified and should be discontinued.
Similar content being viewed by others
References
Pitkala KH, Strandberg TE, Tilvis RS (2001) Is it possible to reduce polypharmacy in the elderly? A randomized, controlled trial. Drugs Aging 18:143–149
Barat I, Andreasen F, Damsgaard EM (2000) The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 56:501–509
Furniss L, Lloyd Craig K, Burns A (1998) Medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 13:433–439
Bhatia SC, Bathia SK (1997) Major depression: selecting safe and effective treatment. Am Fam Physician 55:1683–1698
Muijser RB, Plosker GL, Noble S (2002) Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs Aging 19:377–392
Serby M, Yu M (2003) Overview. Depression in the elderly. Mt Sinai J Med 70:38–44
Barkin RL, Schwer WA, Barkin SJ (2000) Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressant. Am J Ther 7:205–226
Cole MG, Elie LM, McCuster J, Bellavance F, Mansour A (2000) Feasibility and effectiveness of treatment for depression in elderly medical inpatients: a systematic review. Int Psychogeriatr 12:453–461
Steiner D, Marcopulos B (1991) Depression in the elderly. Characteristics and clinical management. Nurs Clin North Am 26:585–600
Bell M, Goss AJ (2001) Recognition, assessment and treatment of depression in geriatric nursing home residents. Clin Excell Nurse Pract 5:26–36
Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M et al (1992) A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 86:138–145
Kates N, Crustolo AM, Farrar S, Nikolaou L (2002) Counselors in primary care: benefits and lessons learned. Can J Psychiatry 47:857–862
Scott J, Thorne A, Horn P (2002) Quality improvement report: effect of a multifaceted approach to detecting and managing depression in primary care. BMJ 26:951–954
American Psychiatric Association. (2000) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington, DC
Mottram P, Wilson K, Copeland J (2000) Validation of the Hamilton Depression Rating Scale and Montgomery and Åsberg Rating Scales in terms of AGECAT depression cases. Int J Geriatr Psychiatry 15:1113–1193
Brown MN, Lapane KL, Luisi AF (2002) The management of depression in older nursing home residents. J Am Geriatr Soc 50:69–76
Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:383–389
Bodlund O, Kullgren G, Ekselius L, Lindström E, von Knorring L (1994) Axis V—Global Assessment of Functioning. Evaluation of a self-report version. Acta Psychiatr. Scand. 90:342–347
Startup M, Jackson MC, Bendix S (2002) The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol 41:417–422
Forsberg C, Björvell H (1993) Swedish population norms for the GHRI, HI and STAI-state. Qual Life Res 2:349–356
Medical Products Agency’s Code of Statutes (2001) LVFS 12 ISSN 1101–5225
Muijsers RB, Plosker GL, Noble S (2002) Spotlight on sertraline in the management of major depressive disorder in elderly patients. CNS Drugs 16:789–794
Ulfvarson J, Adami J, Ullman B, Wredling R, Reilly M, von Bahr C (2003) Randomized controlled intervention in cardiovascular drug treatment in nursing homes. Pharmacoepidemiol Drug Safety 12:589–593
McDonald WM, Salzman C, Schatzberg AF (2002) Depression in the elderly. Psychopharmacol Bull 36[Suppl 2]:121–122
Ekselius L, von Knorring L, Eberhard G (1997) A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychopharmacol 12:323–331
Stahl SM (2000) Placebo-controlled comparison of the selective serotonin reuptake inhibitor citalopram and sertraline. Biol. Psychiatry 48:894–901
Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303–1307
Pacher P, Ungvari Z (2001) Selective serotonin-reuptake inhibitors antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Medical Hypotheses 57:469–471
Movig KL, Leufkens HG, Belitser SV, Lenderink AW, Egberts AC (2002) Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol. Drug Safety 4:271–279
Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH (2003) Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163:59–64
Movig KL, Leufkens HG, Lenderink AW, van den Akker VG, Hoidiamont PP, Goldschmidt HM, Egberts AC (2002) Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol 53:363–369
Acknowledgements
We are grateful to The Swedish Foundation for Health Care Sciences and Allergy Research and the Federation of County Councils, Stockholm County Council, R&D Department. We also thank Jan Golebiowski, M.D., for assessing the patients in the follow-up.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ulfvarson, J., Adami, J., Wredling, R. et al. Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression. Eur J Clin Pharmacol 59, 735–740 (2003). https://doi.org/10.1007/s00228-003-0687-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-003-0687-y